Sarepta shares fall 37% as FDA questions future of key gene therapy
Shares of Sarepta Therapeutics fell close to 37% on Friday after reports emerged that the US Food and Drug Administration is considering
Shares of Sarepta Therapeutics fell close to 37% on Friday after reports emerged that the US Food and Drug Administration is considering
Talen Energy (NYSE: TLN) shares surged over 25% on Friday, reaching $330.99 in intraday trading and setting a new all-time high before
El Salvador, once hailed as the global trailblazer for national Bitcoin adoption, is quietly shifting gears. After making headlines in 2021 for
India’s anti-money laundering agency, the Enforcement Directorate, has summoned officials from Google and Meta on Monday in relation to rising cases of
HDFC Bank, India’s biggest private lender, reported its Q1 FY26 numbers on Saturday, and it was a strong showing. The bank not
Wall Street is heading into a crucial stretch next week as investors are gearing up for a packed schedule: big-name tech earnings,
Elon Musk’s health tech company Neuralink labeled itself a “small disadvantaged business” in a federal filing with the U.S. Small Business Administration,
Microsoft said it will cease using China-based computer engineering teams for work on Pentagon cloud systems and other classified systems after an
The U.S. Environmental Protection Agency (EPA) said Friday it plans to reduce its workforce by 23% and close its research and development